Call for Papers on Clinical Trials

Gastroenterology is committed to advancing clinical practice in the field of digestive disease. Recognizing that clinical trials generally have the greatest impact of all studies on clinical practice, Editor Anil K. Rustgi, MD, and his associate editors strongly encourage authors to submit to Gastroenterology for consideration their manuscripts on clinical trials (diagnostic validation, therapeutic efficacy) of drugs, biological materials and devices in digestive, liver and pancreatic diseases, including studies at phases I, II and especially III. The Journal is also interested in publishing trials in endoscopic and imaging modalities.

There are several important reasons to submit these clinical trials for publication in Gastroenterology.
• With an impact factor of 11.673, Gastroenterology is the premiere journal in the field.
• Gastroenterology is the journal that will directly reach the largest portion of physicians who care for and make treatment decisions for patients with gastrointestinal or liver disease.
• Authors who submit their manuscripts to Gastroenterology will typically receive decisions within three weeks or less-the Journal's time from submission to decision for all types of manuscripts is 23 days.
• Accepted manuscripts will be available online to AGA members and non-member subscribers within two weeks of acceptance.

To submit your manuscript to Gastroenterology, go to www.editorialmanager.com/gastro. For important information on how to report clinical trials, go to http://www.gastrojournal.org/authorinfo. To review the current and past issues of the journal, go to www.gastrojournal.org.